Endocrine oncology

pT1a papillary thyroid carcinomas in pediatric patients

Eur Thyroid JPublished Retrospective cohort study

Authors' conclusion

iPTC may be found in 5.1% of pediatric patients undergoing thyroidectomy for benign conditions. Similar to adults, iPTC in pediatric patients appears to be indolent with a minimal risk for invasive features and a low risk for persistent or recurrent disease. In contrast to iPTC, niPTC exhibits the potential for invasive behavior and should be regarded as a distinct entity.

Study context

Population
Pediatric patients who underwent thyroidectomy and were diagnosed with pT1a PTC, Children's Hospital of Philadelphia, August 2010–February 2023pT1a PTC cohort
Participants
66 patients
Exposure
Incidental PTC vs non-incidental PTC
  • Incidental PTC (iPTC)n = 23
  • Non-incidental PTC (niPTC)n = 43reference
Outcome
Incidence of iPTC in thyroidectomy for benign conditions
Methodological detailsretrospective chart review, single-centre
  • Retrospective chart review
  • Single-centre

Main finding

As reported in the abstract

iPTC identified in patients undergoing thyroidectomy for benign conditions

23 of 453

5.1%

Observational data: associations, not effects.

Further findings

Greatest dimension · smaller with iPTC

P < 0.001

Lymphatic invasion

P < 0.001

AJCC N1 disease

P < 0.001

ATA pediatric risk category

ATA pediatric low-risk iPTC 22 out of 23 (95.7%)

Intermediate/high-risk niPTC six out of 43 (14.0%)

OutcomeiPTCniPTC
Persistent or recurrent disease · median follow-up 3.3 (iPTC) and 5.7 (niPTC) years0 events— not stated in the abstract

— not stated in the abstract

  • ATA pediatric risk category: iPTC value is low-risk; niPTC value is intermediate/high-risk

Persistent or recurrent disease · median follow-up 3.3 (iPTC) and 5.7 (niPTC) years

No evidence of persistent or recurrent disease in any patient with iPTC

Original publication

pT1a papillary thyroid carcinomas in pediatric patients. Eur Thyroid J. Published 9 October 2025. doi:10.1530/etj-25-0119

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.